*1 Before: COLE and GRIFFIN, Circuit Judges; GWIN, District Judge. [*] _________________
COUNSEL ARGUED: Eric Alan Isaacson, ROBBINS GELLER RUDMAN & DOWD LLP, San Diego, California, for Appellants. Harvey Kurzweil, WINSTON & STRAWN LLP, New York, New York, for Appellees. ON BRIEF: Eric Alan Isaacson, Henry Rosen, Jennifer L. Gmitro, Amanda M. Frame, ROBBINS GELLER RUDMAN & DOWD LLP, San Diego, California, for Appellants. Harvey Kurzweil, Richard W. Reinthaler, John E. Schreiber, WINSTON & STRAWN LLP, New York, New York, Wm. T. Robinson * The Honorable James S. Gwin, United States District Judge for the Northern District of Ohio, sitting by designation.
1
III, Michael E. Nitardy, FROST BROWN TODD LLC, Florence, Kentucky, for Appellees.
COLE, J., delivered the opinion of the court in which GRIFFIN, J., and GWIN, D. J., joined. GWIN, J. (pp. 18–19), delivered a separate concurring opinion.
_________________
OPINION _________________ COLE, Circuit Judge. Plaintiffs, all Omnicare investors, appeal the dismissal of their securities suit under § 11 of the Securities Act of 1933, 15 U.S.C. § 77k (2010), against Defendants Omnicare, Inc., its officers, and directors. Plaintiffs allege that Defendants made material misstatements and/or omissions in a Registration Statement filed with the Securities and Exchange Commission in connection with a December 2005 public stock offering. The district court held that Plaintiffs had not adequately pleaded knowledge of wrongdoing on the part of Defendants and dismissed the complaint for failure to state a claim upon which relief can be granted. Plaintiffs seek reversal of the district court’s dismissal order on the grounds that § 11 is a strict liability provision. For the following reasons, we REVERSE and REMAND in part and AFFIRM in part.
I.
Defendant Omnicare is the nation’s largest provider of pharmaceutical care
services for the elderly and other residents of long-term care facilities in the United
States and Canada.
Ind. State Dist. Council v. Omnicare Inc
.,
Plaintiffs are investors who purchased Omnicare securities in a December 15, 2005, public offering. In conjunction with the public offering, Omnicare offered 12.8 million shares of common stock and made related filings with the Securities and Exchange Commission. These filings were incorporated into a Registration Statement which is central to the current litigation. Plaintiffs did not hold the stock long. They sold all of these securities by January 31, 2006.
Plaintiffs seek relief under § 11 of the Securities Act of 1933, 15 U.S.C. § 77k. Section 11 provides a remedy for investors who have acquired securities under a registration statement that was materially misleading or omitted material information. It imposes liability on issuers and signers of registration statements containing untrue statements or omissions of material fact. 15 U.S.C. § 77k(a). Section 11 also imposes liability on the directors of the issuer. Id. at § 77k(a)(2).
According to the Third Amended Complaint [2] , Omnicare was engaged in a variety of illegal activities including kickback arrangements with pharmaceutical manufacturers and submission of false claims to Medicare and Medicaid. Plaintiffs allege that representations in the Registration Statement were material, untrue and misleading because they effectively concealed Omnicare’s illegal activities from its investors. According to the Plaintiffs, the Registration Statement stated “that [Omnicare’s] therapeutic interchanges were meant to provide [patients with] . . . more efficacious and/or safer drugs than those presently being prescribed” and that its contracts with drug companies were “ legally and economically valid arrangements that bring value to the healthcare system and patients that we serve.” Plaintiffs claim that given Omnicare’s alleged illegal activities, these and other statements indicating compliance with the law 1 According to Defendants, Mr. Hutton is deceased. 2 Although the Third Amended Complaint is titled “Second Amended Consolidated Complaint,”
it is the third amendment to the original complaint in this litigation. The parties and the district court have consistently referred to it as the “Third Amended Complaint.” *4 were misleading. Specifically, Plaintiffs allege that these statements of “legal compliance” made in the Registration Statement were material, false and misleading, and therefore in violation of § 11.
Furthermore, Plaintiffs allege that Omnicare failed to comply with Generally Accepted Accounting Principles (“GAAP”), such that the financial statements filed in connection with the December 2005 public offering substantially overstated the company’s revenue. Therefore, according to Plaintiffs, the financial statements contained material misstatements and omissions in violation of § 11.
Plaintiffs filed this case in the United States District Court for the Eastern District of Kentucky in February 2006 as a putative securities class action, alleging claims for violations of § 10(b), Rule 10b-5 and § 20(a) of the Securities and Exchange Act of 1934. Omnicare I , 583 F.3d at 939. A class was never certified. Plaintiffs later amended the complaint, adding a claim under § 11 for material misstatements and omissions in the Registration Statement. That § 11 claim is the basis of the instant appeal.
Defendants moved to dismiss the complaint on a variety of grounds. On October
12, 2007, the district court granted Defendants’ motion and dismissed the complaint in
its entirety.
Omnicare
,
On October 21, 2009, this Court affirmed the judgment of the district court with
respect to all claims except the § 11 claim. We held that “loss causation” is not an
element of a § 11 claim but is instead an affirmative defense. ,
Plaintiffs pursued a writ for certiorari, which they later dismissed, and then moved for leave to amend the complaint in order to re-plead the § 11 claim. The motion was granted. The Third Amended Complaint encompasses two types of § 11 allegations: (1) material misstatements and omissions made with reference to the statements of “legal compliance”; and (2) material misstatements and omissions in reference to GAAP. Defendants filed a motion to dismiss the Third Amended Complaint.
On February 13, 2012, the district court granted Defendants’ motion, concluding that because the Plaintiffs’ § 11 claim “sounds in fraud,” it was subject to but failed to meet the heightened pleading standard of Federal Rule of Civil Procedure 9(b). The court furthermore held that, for both claims asserted under § 11, Plaintiffs were required, but failed to plead, knowledge of falsity on the part of the Defendants. Because the court found that the complaint failed to satisfy the pleading standards of Rule 9(b), and because Plaintiffs had not sufficiently pleaded Defendants’ knowledge of falsity, the complaint was dismissed. Plaintiffs again appealed.
II.
Whether the district court properly dismissed a complaint pursuant to Federal
Rule of Civil Procedure 12(b)(6) is a question of law subject to de novo review.
Kottmyer v. Maas
,
While notice pleading requirements are based on Rule 8,
see Twombly
, 550 U.S.
at 555, claims for fraud are held to the heightened pleading standard of Rule 9(b). We
held in that, although § 11 claims do not require pleading of scienter, Rule
*6
9(b) pleading standards still apply to § 11 claims that sound in fraud.
Omnicare I
,
Plaintiffs argue that, since this Court’s decision in
Omnicare I
, they have
amended their complaint to abandon all claims “that could be construed as alleging fraud
or intentional or reckless misconduct” and that, as a result, Rule 9(b) no longer applies.
They base this argument primarily on a disclaimer that has been added to the complaint
stating: “Plaintiffs expressly exclude and disclaim any allegation that could be construed
as alleging fraud or intentional or reckless misconduct, as this claim is based solely on
the theories of strict liability and negligence under the Securities Act.” This one-
sentence disclaimer, however, does not achieve Plaintiffs’ desired result.
See Cal. Pub.
Emps. Ret. Sys. v. Chubb Corp.,
Complaints subject to Rule 9(b) must plead “with particularity the circumstances
constituting fraud or mistake.” Fed. R. Civ. P. 9(b). In order to meet the “particularity”
requirement of Rule 9(b), “a plaintiff [must] allege the time, place, and content of the
alleged misrepresentations on which he or she relied; the fraudulent scheme; the
fraudulent intent of the defendants; and the injury resulting from the fraud.”
Sanderson
v. HCA-The Healthcare Co.
,
III.
Plaintiffs have brought two separate § 11 claims in their Third Amended Complaint: one for material misstatements and/or omissions of legal compliance and one for Defendants’ alleged failure to comply with GAAP such that the Registration Statement contained material misstatements and/or omissions. We address each of these claims in turn.
A.
1. Plaintiffs allege that Omnicare’s statements of legal compliance led investors to believe that Omnicare—which was allegedly engaged in illegal activities—was in compliance with the law. Plaintiffs assert that these statements of legal compliance made in the Registration Statement were therefore material, untrue, and misleading, in violation of § 11.
The district court held that Plaintiffs were required to plead that Defendants knew that the statements of legal compliance were false at the time they were made. Because the court found that Plaintiffs failed to plead knowledge of falsity, it dismissed the complaint for failure to state a claim. On appeal, Plaintiffs argue that § 11 provides for strict liability and it was therefore inappropriate for the district court to require them to plead knowledge in connection with their § 11 claim. We agree.
Section 11 provides for the imposition of liability if a registration statement, as
of its effective date, “contained an untrue statement of a material fact or omitted to state
a material fact required to be stated therein or necessary to make the statements therein
not misleading.” 15 U.S.C. § 77k(a). It provides a remedy for investors who have
acquired securities pursuant to a registration statement that was materially misleading
or omitted material information.
See Herman & MacLean v. Huddleston
,
Defendants respond, however, that the issue is not so simple. Section 10(b) of
the Securities and Exchange Act of 1934, 15 U.S.C. § 78j(b), and Rule 10b-5, 17 C.F.R.
§ 240.10b-5, have elements parallel to § 11, prohibiting “fraudulent, material
misstatements or omissions in connection with the sale or purchase of a security.”
Miller v. Champion Enters. Inc.
,
A thornier issue arises when a defendant chooses to disclose some soft information, as occurred in the instant case. Defendants were not completely silent, but instead spoke on issues of legal compliance. With regard to § 10(b) and Rule 10b-5, this Court has reasoned:
[T]he protections for soft information end where speech begins . . . . : [H]ow can a rule of non-disclosure apply to a company’s disclosure? If—as defendants contend—the protection for soft information remains intact even after a company speaks on an emerging issue, the speaker could choose which contingencies to expose and which to conceal. On any subject falling short of reasonable certainty, then, a company could offer a patchwork of honesty and omission. This proposition is untenable . . . .
Helwig v. Vencor, Inc.
,
In , this Court addressed Plaintiffs’ § 10(b) and Rule 10b-5 claims
regarding statements of legal compliance. The Court reasoned, citing
Kushner v. Beverly
Enterprises
,
Inc
.,
The
Omnicare I
panel relied heavily on
Kushner
, which had in turn relied heavily
on our
Helwig
and
Sofamor
opinions.
See Omnicare I
,
Language in Helwig supports the view taken by the Eighth Circuit in Kushner for purposes of § 10b and Rule 10b-5. In Helwig , this Court stated: “With regard to future events, uncertain figures, and other so-called soft information, a company may choose silence or speech elaborated by the factual basis as then known . . . .” 251 F.3d at 561 (emphasis added). In other words, a company that chooses to disclose soft information assumes the duty to do so fully and truthfully, but only to the extent that facts are known at the time the statements are made. Helwig , Kushner and , therefore appear to indicate that, in § 10(b) and Rule 10b-5 cases, a plaintiff must plead knowledge of falsity because there can be no liability for a material misstatement if a defendant was not aware there was anything further to disclose in order to correct the misstatement.
Defendants now argue that the same reasoning should apply under § 11 to the
case at hand. We do not agree. Section 10(b) and Rule 10b-5 require a plaintiff to prove
scienter, § 11 is a strict liability statute. It makes sense that a defendant cannot be liable
for a fraudulent misstatement or omission under § 10(b) and Rule 10b-5 if he did not
know a statement was false at the time it was made. The statement cannot be fraudulent
if the defendant did not know it was false. Section § 11, however, provides for strict
liability when a registration statement “contain[s] an untrue statement of a material fact.”
15 U.S.C. 77k(a);
see Huddleston
,
It is immaterial that this issue has been framed as a disclosure requirement. Disclosed information can nevertheless be indisputably wrong. Under the language of § 10(b) and Rule 10b-5, a defendant may take shelter in the fact that she did not know there was anything further to disclose; it was not fraudulent for the defendant to fail to disclose anything further. A plaintiff therefore fails to state a claim if she has not pleaded knowledge of falsity. Under § 11, however, if the defendant discloses information that includes a material misstatement, that is sufficient and a complaint may survive a motion to dismiss without pleading knowledge of falsity.
Finally, Defendants urge us to follow
Fait v. Regions Financial Corp
., 655 F.3d
105 (2d Cir. 2011). In
Fait
, a case similar to the instant one, the Second Circuit held
“when a plaintiff asserts a claim under section 11 . . . based upon a belief or opinion
alleged to have been communicated by a defendant, liability lies only to the extent that
the statement was both objectively false and disbelieved by the defendant at the time it
was expressed.”
Id
. at 110 (citing
Virginia Bankshares, Inc. v. Sandberg
,
While Defendants are correct that we are bound by Supreme Court precedent, we see nothing in Virginia Bankshares that alters the outcome in the instant case, and we decline to follow the Second and Ninth Circuits as a result. Reserving the question of whether scienter is necessary to make out a § 14(a) claim, the Supreme Court held in Virginia Bankshares that a plaintiff may bring a claim under § 14(a) of the Securities and Exchange Act of 1934 for a material misstatement or omission even if the statement is vague and conclusory. Virginia Bankshares , 501 U.S. at 1093 (“[S]uch conclusory terms in a commercial context are reasonably understood to rest on a factual basis that justifies them as accurate, the absence of which renders them misleading”); 15 U.S.C § 78n(a). The Court furthermore held that a defendant’s disbelief in his own statement is not enough, on its own, for a plaintiff to make out a claim for a material misstatement under § 14(a). Id. at 1090, 1095-96. In other words, under § 14(a) a plaintiff is required to plead objective falsity in order to state a claim; pleading belief of falsity alone is not enough. Id. at 1095-96 (“proof of mere disbelief or belief undisclosed [standing alone] should not suffice for liability under § 14(a)”). In the instant case, the Plaintiffs have pleaded objective falsity. The Virginia Bankshares Court was not faced with and did not address whether a plaintiff must additionally plead knowledge of falsity in order to state a claim. . It therefore does not impact our decision today.
The Court, at the same point that it declined to discuss scienter, also explicitly limited its discussion to statements of opinion and belief that it presumed were made with knowledge of falsity: “[W]e interpret the jury verdict as finding that the directors’ statements of belief and opinion were made with knowledge that the directors did not hold the beliefs or opinions expressed, and we confine our discussion to statements so made.” Id . at 1090. A footnote to this sentence reserves “the question whether scienter [is] necessary for liability . . . under § 14(a).” . at 1090 n.5. The connection of these two statements indicates that the Virginia Bankshares Court itself tied the knowledge of falsity requirement to scienter but explicitly declined to address the issue further. Instead, it assumed the jury in the case had already found knowledge of falsity—whether necessary or not—and proceeded from there. See id . at 1090.
The Second and Ninth Circuits have read more into
Virginia Bankshares
than the
language of the opinion allows and have stretched to extend this § 14(a) case into a § 11
context. Since the Supreme Court assumed knowledge of falsity for the purposes of the
discussion in
Virginia Bankshares
, § 14(a) was effectively treated as a statute that
required scienter.
[3]
The
Virginia Bankshares
discussion, therefore, has very limited
application to § 11; a provision which the Court has already held to create strict liability.
See Huddleston
,
The Second Circuit reads Justice Scalia’s concurring opinion as support for their
interpretation of
Virginia Bankshares
.
See Fait
, 655 F.3d at 111 (citing
Virginia
Bankshares
,
2.
We construe facts alleged in the complaint in the light most favorable to the
Plaintiffs and accept all factual allegations as true.
Kottmyer
, 436 F.3d at 688;
see
Tellabs, Inc., v. Makor Issues & Right, Ltd.
,
Defendants first argue that Plaintiffs’ citations to
qui tam
complaints are
insufficient to sustain their claim. In order to support this argument, Defendants first
contend that Plaintiffs have failed to conduct a “reasonable investigation” as required
under Rule 11.
See Alrbright v. Upjohn Co.
,
Defendants next argue that allegations based on
qui tam
complaints nevertheless
cannot withstand a motion to dismiss under Rule 9(b). Defendants cite to several cases
in which courts, after noting reliance on third-party actions, have dismissed complaints
under Rule 9(b). We do not believe this case necessitates such action. The only Sixth
Circuit opinion cited by Defendants,
Konkol v. Diebold, Inc.,
The same is not true in the instant case. Plaintiffs do not simply cite to the
existence
of government investigations, they allege numerous reasons why the facts of
those investigations support their claim. In
Konkol
, the plaintiffs relied on the fact that
government agencies had dedicated resources to investigating defendants, and they
therefore concluded, “as a matter of common sense,” that something must be amiss. .
at 401-02. The Plaintiffs here jump to no such conclusions. Instead of relying on the
mere existence of
qui tam
complaints or investigations, they comprehensively discuss
4
We also note that plaintiffs in
Konkol
were not only subject to Rule 9(b) but also to the higher
more exacting pleading standards of the Private Securities Litigation Reform Act, 15 U.S.C. § 78u-4(b),
which are inapplicable in this case.
Konkol
,
Defendants’ second argument is that the confidential witness statements in the
complaint should be “steeply discounted.”
See Omnicare I
,
B.
Plaintiffs also appeal the dismissal of their § 11 claim for GAAP-based
misstatements and omissions. The district court held that Plaintiffs failed to plead
knowledge of falsity and therefore failed to state a claim. Defendants argue that we
should affirm because the GAAP allegations are based on “soft information.”
Cf. In re
Almost Family, Inc
.
Sec. Litig
., No. 3:10-CV-00520-H,
However, Plaintiffs still have to meet the particularity requirements of Rule 9(b) in pleading that GAAP violations occurred. As this Court noted in Omnicare I , Plaintiffs’ GAAP allegations appear to contain some factual holes. In assessing Plaintiffs’ 10(b) and 10b-5 claims, the Court stated:
Although Plaintiffs list numerous alleged violations of GAAP rules, the complaint nowhere suggests how or when any of these alleged accounting improprieties were disclosed. Rather, Plaintiffs argue that they were implicitly disclosed because Omnicare’s allegedly illegal conduct (drug recycling, etc.) translated into accounting violations. Thus, when news of the government raids appeared, the accounting statements were thrown into question by extension. This causation theory, however, rests entirely on speculation and is substantially undercut both by the lack of any financial restatements on Omnicare’s part and by the willingness of third-party auditors to continue to certify Omnicare’s GAAP compliance.
Omnicare I
,
While that analysis concerned whether Plaintiffs had adequately alleged “loss causation” with particularity, it is applicable to whether they have pleaded a GAAP violation at all. Plaintiffs’ Third Amended Complaint alleges many GAAP-based violations, but as the Court noted in Omnicare I , the details of the accounting violations remain unclear. Although Plaintiffs’ complaint has been amended since our previous opinion, Plaintiffs have not pointed to any updated information that would resolve these issues.
C.
Defendants urge us to affirm the district court on the alternative ground that the
affirmative defense of loss causation is evident on the face of the complaint. “Loss
causation” refers to the causal connection between the defendant’s material
misrepresentation or omission and the plaintiff’s loss.
See Omnicare
, 527 F. Supp. 2d
at 704-05. When an affirmative defense is evident on the face of a complaint, the
complaint may be subject to dismissal under Rule 12(b)(6).
Jones v. Bock
,
Loss causation is an element of a § 10(b) and Rule 10b-5 claim but only an affirmative defense to a § 11 claim. The Omnicare I panel reversed the district court on *17 the § 11 claim on exactly that basis. Had the Court determined that the affirmative defense of loss causation was evident from the face of the pleadings, it would have affirmed and dismissed the case. Instead, it chose to remand to the district court for further analysis. Id. at 948. The district court, having declined to reach this issue on remand, has not yet addressed the merits of the argument. Although the complaint has been amended since Omnicare I was decided, the Defendants urge us to find loss causation on the basis of language in the outdated complaint. We therefore have no more information on this issue now than we had at the time of the Omnicare I opinion.
“When attention has been focused on other issues, or when the court from which
a case comes has expressed no views on a controlling question, it may be appropriate to
remand the case rather than deal with the merits of that question in this Court.”
Dandridge v. Williams
,
IV.
For the foregoing reasons, we REVERSE the district court with regard to Plaintiffs’ legal compliance claims and REMAND for further proceedings consistent with this opinion; and AFFIRM with respect to Plaintiffs’ GAAP-based claims.
____________________________
CONCURRENCE
____________________________ GWIN, District Judge, concurring. I concur in the majority’s thoughtful and comprehensive opinion. I write separately to make clear that the district court retains the statutory and inherent discretion to resurrect previously dismissed claims and previously dismissed parties should later discovered evidence warrant it. See Rodriguez v. Tenn. Laborers Health & Welfare Fund , 89 F. App’x 949, 959 (6th Cir. 2004) (“District courts have authority both under common law and Rule 54(b) to reconsider interlocutory orders and to reopen any part of a case before entry of final judgment.”).
Rule 54(b) of the Federal Rules of Civil Procedure provides the statutory vehicle
for such revision. If a court decides fewer than all the claims presented, as is the case
here, dismissed claims can be revived until the entry of final judgment. Fed. R. Civ. P.
54(b) (“[A]ny order . . . that adjudicates fewer than all the claims or the rights and
liabilities of fewer than all the parties does not end the action as to any of the claims or
parties and may be revised at any time before the entry of a judgment adjudicating all
the claims and all the parties’ rights and liabilities.”). The district court’s ability to
reconsider past rulings must be tempered by “the sound public policy that litigation be
decided and then put to an end.”
Petition of U.S. Steel Corp.
,
In deciding whether to revisit previously dismissed claims or parties, a district
court may consider “(1) an intervening change of controlling law; (2) new evidence
available; or (3) a need to correct a clear error or prevent manifest injustice.”
Rodriguez
,
Rule 54(b) is particularly relevant in suits subject to the Private Securities
Litigation Reform Act (PSLRA). The PSLRA, passed in 1995 after considerable
lobbying by corporate and investment interests, mandates heightened pleading
*19
requirements to avoid dismissal. As one scholar notes, the PSLRA “created a super-
heightened pleading standard for certain aspects of securities claims and deferred
discovery until after resolution of an inevitably protracted motion to dismiss . . . .”
Arthur Miller,
From
Conley
to
Twombly
to
Iqbal:
A Double Play on the Federal Rules
of Civil Procedure
, 60 Duke L.J. 1, 11 (2010). Such motions to dismiss, as is the case
here, often
include questions of “scienter,
loss causation, reliance, and
materiality—questions that formerly would have been considered trial worthy.”
Id.
Remarkably, the PSLRA imposes what amounts to a probabilistic pleading standard for
scienter.
See Tellabs v. Makor Issues & Rights, Ltd.
,
If newly-found evidence in a PSLRA case supports a previously dismissed claim’s scienter (or materiality, or reliance, or loss causation) allegation, the district court could allow the claim to be revived. District courts are charged with enforcing rules “to secure the just, speedy, and inexpensive determination” of an action. Fed. R. Civ. P. 1. There’s a reason that “just” precedes “speedy.”
